These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26564071)

  • 1. Neurofibromatosis type 1.
    Anderson JL; Gutmann DH
    Handb Clin Neurol; 2015; 132():75-86. PubMed ID: 26564071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomas in patients with neurofibromatosis type 1.
    Albers AC; Gutmann DH
    Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1.
    Gutmann DH; Ferner RE; Listernick RH; Korf BR; Wolters PL; Johnson KJ
    Nat Rev Dis Primers; 2017 Feb; 3():17004. PubMed ID: 28230061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ossifying Fibroma of Maxilla in a Female Affected by Neurofibromatosis Type 1.
    Jendi SK; Khatib S; Mistry J; Wagh A; Vaidya K; Kokane G
    Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 3):2087-2090. PubMed ID: 31763299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neurofibromatoses. Part 1: NF1.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(2):E47-53. PubMed ID: 19587630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lisch nodule in neurofibromatosis type 1].
    Abaloun Y; Ajhoun Y
    Pan Afr Med J; 2017; 27():218. PubMed ID: 28979620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis 1 in childhood.
    North KN
    Semin Pediatr Neurol; 1998 Dec; 5(4):231-42. PubMed ID: 9874851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic aspects of neurofibromatosis 1.
    Jett K; Friedman JM
    Genet Med; 2010 Jan; 12(1):1-11. PubMed ID: 20027112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
    De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
    Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 1 - description of clinical features and molecular mechanism of the disease].
    Bikowska-Opalach B; Jackowska T
    Med Wieku Rozwoj; 2013; 17(4):334-40. PubMed ID: 24519776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.